United Asset Strategies Inc. Has $4.55 Million Holdings in The Clorox Company (NYSE:CLX)

United Asset Strategies Inc. raised its position in The Clorox Company (NYSE:CLX - Free Report) by 75.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 31,892 shares of the company's stock after acquiring an additional 13,726 shares during the quarter. United Asset Strategies Inc.'s holdings in Clorox were worth $4,547,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in CLX. Norges Bank purchased a new stake in shares of Clorox during the 4th quarter worth approximately $101,609,000. Imprint Wealth LLC lifted its position in shares of Clorox by 16,986.8% during the 2nd quarter. Imprint Wealth LLC now owns 551,392 shares of the company's stock worth $55,139,000 after buying an additional 548,165 shares during the last quarter. Qube Research & Technologies Ltd lifted its position in shares of Clorox by 75.9% during the 3rd quarter. Qube Research & Technologies Ltd now owns 1,130,481 shares of the company's stock worth $148,161,000 after buying an additional 487,974 shares during the last quarter. International Assets Investment Management LLC lifted its position in shares of Clorox by 17,658.5% during the 4th quarter. International Assets Investment Management LLC now owns 484,453 shares of the company's stock worth $69,078,000 after buying an additional 481,725 shares during the last quarter. Finally, Acadian Asset Management LLC lifted its position in shares of Clorox by 39.6% during the 3rd quarter. Acadian Asset Management LLC now owns 1,467,713 shares of the company's stock worth $192,319,000 after buying an additional 415,999 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Stock Performance

CLX traded up $1.91 during trading on Tuesday, hitting $142.44. The stock had a trading volume of 1,053,239 shares, compared to its average volume of 1,214,925. The company has a debt-to-equity ratio of 11.37, a quick ratio of 0.57 and a current ratio of 0.89. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $178.21. The firm has a market capitalization of $17.68 billion, a P/E ratio of 226.10, a PEG ratio of 2.21 and a beta of 0.43. The company's 50-day moving average price is $150.67 and its 200 day moving average price is $141.68.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, topping analysts' consensus estimates of $1.08 by $1.08. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The business had revenue of $1.99 billion for the quarter, compared to analysts' expectations of $1.80 billion. During the same period in the prior year, the company posted $0.98 EPS. The business's revenue for the quarter was up 16.0% on a year-over-year basis. On average, equities research analysts forecast that The Clorox Company will post 5.52 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be paid a dividend of $1.20 per share. The ex-dividend date is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.37%. Clorox's dividend payout ratio (DPR) is presently 761.92%.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. UBS Group boosted their price objective on shares of Clorox from $145.00 to $170.00 and gave the stock a "neutral" rating in a research report on Friday, February 2nd. Morgan Stanley reaffirmed an "equal weight" rating and issued a $160.00 target price on shares of Clorox in a report on Tuesday, March 26th. DA Davidson reaffirmed a "neutral" rating and issued a $162.00 target price on shares of Clorox in a report on Monday, February 5th. The Goldman Sachs Group assumed coverage on shares of Clorox in a report on Friday, March 1st. They issued a "sell" rating and a $140.00 target price on the stock. Finally, Citigroup cut their target price on shares of Clorox from $165.00 to $155.00 and set a "neutral" rating on the stock in a report on Tuesday. Four research analysts have rated the stock with a sell rating and twelve have issued a hold rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $148.50.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.